Patent details

Basic Information

Publication number:

EP0876366

PCT Application Number:

PCT/EP/97/00201

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP979010592

PCT Publication Number:

WO/97/26258

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANGIOGENESIS INHIBITING PYRIDAZINAMINES

French Title of Invention:

PYRIDAZINAMINES INHIBANT L'ANGIOGENESE

German Title of Invention:

ANGIOGENESIS HEMMENDE PYRIDAZINAMINE

SPC Number:

Dates

Filing date:

14/01/1997

Grant date:

25/07/2001

EP Publication Date:

25/07/2001

PCT Publication Date:

24/07/1997

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/11/1998

EP B1 Publication Date:

25/07/2001

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/01/2008

Expiration date:

14/01/2017

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/01/1997

 

 

Name:

JANSSEN PHARMACEUTICA N.V.

Address:

Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/07/2001

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MEERPOEL Lieven

Address:

Belgium (BE)

2

Name:

STOKBROEKX Raymond, Antoine Janssen

Address:

Belgium (BE)

3

Name:

VAN DER AA Marcel, Jozef, Maria Janssen

Address:

Belgium (BE)

4

Name:

LUYCKX Marcel, Gerebernus, Maria Janssen

Address:

Belgium (BE)

5

Name:

WILLEMS Marc Janssen Pharmaceutica N.V.

Address:

Belgium (BE)

6

Name:

TUMAN Robert, W. Janssen Research Foundation

Address:

United States (US)

Priority

Priority Number:

96200085

Priority Date:

15/01/1996

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07D 417/04;

Filing date	Document type	Number of pages